2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Handwriting Based Screening of Parkinson’s Disease Using Image Analysis of Drawing Tasks

A. Shih, L. Cruz-Mondragon, V. Santini, S. Panchawagh (Winston-Salem, USA)
Handwriting in PRKN-PD: A Study of Movement Control

A. Gallagher, C. Fearon, T. Lynch (Dublin, Ireland)
Harmonized Analysis of Parkinson’s Disease-Associated Variants in the AfrAbia PD Genomic Consortium Cohort

WMY. Mohamed (Kuantan, Malaysia)
Harnessing the Local Wisdom of Central Kalimantan’s Eleutherine palmifolia (Dayak Onion) in Parkinson’s Disease Therapy: A Molecular Docking and Ethnopharmacological Study”

NIN. Surbakti, LIF. Sayyidinoor, YAN. Antonio, RIF. Akbar (Palangka Raya, Indonesia)
HD-RAC (Huntington’s Disease Research at Convention) Series: Novel approach to pilot data collection for outcome measures in Huntington’s disease

S. Sathe, M. Roche, R. Fuller, G. Phelan, C. Harwood, S. Lacy, S. Lazic, S. Smith, H. Wilkinson, C. Sampaio (Princeton, USA)
Head Trauma History and Motor Phenotype in Early Parkinson’s Disease

HL. Lee, SM. Choi (Gwangju, Republic of Korea)
Health-Related Quality of Life in patients with Parkinson’s disease based on the ICF model

S. Shtaimets, N. Zhukova, I. Zhukova, D. Novotnyy, A. Agasheva (Tomsk, Russian Federation)
Healthcare Professionals’ Perceptions of using eHealth in the Rehabilitation of Progressive Disease: A Qualitative Study

B. Leavy, C. Quinn, C. Malinowsky, H. Johansson (Huddinge, Sweden)
Healthcare Resource Utilization and Associated Costs in Adults with Isolated Dystonia in the United States

M. Oldham, J. Kerner, S. Dasgupta, J. Imperato, J. Thornton (Cambridge, USA)
Healthcare Resource Utilization and Costs of Multiple System Atrophy in the United States: An Observational Database Study

S. Wald Grossman, A. Rieckmann, A. Mehta (Deefield, USA)
Healthcare Utilization and Economic Burden in Patients with Friedreich’s Ataxia: Baseline Results of the PROFA Study

D. Sarwinska, A. Iskandar, M. Buchholz, T. Klockgether, S. Borel, F. Xie, E. Davies, K. Reetz, L. Schöls, T. Klopstock, S. Boesch, B. Michalowsky (Greifswald, Germany)
Heart Rate Variability as an Independent Predictive Biomarker for Fall Risk in Multiple System Atrophy

R. Rajput, V. Sharma (New Delhi, India)
Heart Rate Variability in Early Parkinson’s Disease

SJ. Chung, D. Kang, J. Lee, PH. Lee, YJ. Kim, YH. Sohn (Seoul, Republic of Korea)
Hemidystonia Beyond the Basal Ganglia: Etiological Heterogeneity in an 11 Patient Case Series

H. Canfield Medina, L. Santos, C. Ordas Bandera, A. Querejeta Coma (Madrid, Spain)
Hemoglobin Levels and Non Motor Symptoms in Parkinsons Disease Patients with Modified Hoehn and Yahr Scores

F. Hukmiyya, E. Pasmanasari, A. Wati, S. Santoso (Semarang, Indonesia)
Hepatic Biomarker Profile Across Parkinson’s Disease Severity Stages in a Peruvian Cohort

J. Moya-Salazar, F. Peralta-Hilario, I. Pasco, B. Cañari, A. Sobrino-Galindo, H. Contreras-Pulache (Chiclayo, Peru)
Hereditary Adult-Onset Generalized Dystonia Associated with Pathogenic IRF2BPL Mutation

J. Plagenz, T. Harlow (Fargo, USA)
Heterogeneous Responsiveness to Combined Motor–Cognitive Exercise in Parkinson’s Disease: A Latent Class Analysis

J. Hwang, C. Youm, H. Park, M. Kim, B. Kim, S. Cheon (busan, Republic of Korea)
High Frequency of Neurological Soft Signs in Prospectively Evaluated Essential Tremor Patients

L. Gattermeyer-Kell, M. Suette, M. Zangl, P. Schwingenschuh (Graz, Austria)
High Frequency of Pathogenic Variants in Neurodevelopmental Genes in Patients with Dystonia

L. Welzel, M. Thomsen, G. Kilic-Berkmen, S. Loens, E. Lohmann, AH. Tan, S. Frank, A. Lang, J. Perlmutter, M. Möller, S. Franzenburg, SY. Lim, A. Münchau, HA. Jinnah, H. Busch, T. Bäumer, D., D., C. Klein, K. Lohmann (kamm,odorfer,pfister,zeuner,zittel)
High Step Marching Dyskinesia: A Case Series

N. Pulley, I. Bledsoe, P. Hoang (San Francisco, USA)
High-dimensional proteomic profiling in plasma and CSF identifies molecular signatures in Parkinson’s disease

S. Rota, B. Batzu, M. Veronese, J. Shubert, A. Heslegrave, B. Fernandes Gomes, A. Reith, C. Parker, S. Lee, N. Barwick, S. Williams (London, United Kingdom)
High-Frequency rTMS for Cognitive Impairment in Parkinson’s Disease: A Randomized Sham-Controlled Trial in Veterans

Y. Kim, S. Walker, K. Colletta, A. Umbarger, S. Kletzel (Maywood, USA)
High-Intensity Multimodal Training Through Group-Based Weighted Dance for Parkinson’s Disease: A Feasibility Study

Y. Chen, S. Lai, C. Xu, K. Liu, L. Lo, T. Cheng, C. Li, C. Lui, Y. Wang, J. Jiang, Y. Wang, M. Huang (Kowloon, Hong Kong)
Higher Dopaminergic Sensitivity Underlies Dyskinesia Occurrence in Indigenous Sabahan PRKN Parkinson’s Disease

JCE. Ooi, YK. Chia, YW. Tay, TZ. Toh, A. Ahmad-Annuar, S-Y. Lim, AH. Tan (Kota Kinabalu, Malaysia)
Hip and Elbow Joint Angle Characteristics of Patients with Parkinson’s Disease

D. Rasmiyani, A. Husni, E. Pasmanasari, A. Wati (Semarang, Indonesia)
Hip fractures in Parkinson’s Disease: A single-centre retrospective cohort study

A. Mackett, O. Kurn, A. Jesuthasan, C. Cox (Cambridge, United Kingdom)
Holistic Sensor-Based Profiling of Parkinson’s Disease via Mixed Reality: Implementation and Multimodal Feasibility

W. Szecowka, M. Wojcik-Pedziwiatr, M. Baran, J. Stepien, P. Jemiolo, N. Bozetine, M. Dudek, J. Krzywdziak, M. Zbik, D. Hemmerling, M. Rudzynska-Bar (Warsow, Poland)
Holmes Tremor Secondary to Structural Brain Lesions: A Case Series from a Tertiary National Referral Hospital

D. Prameswari, A. Tiksnadi, F. Abdat, D. Tunjungsari (Jakarta, Indonesia)
Home-based cerebellar transcranial stimulation for multiple system atrophy: A randomized trial

YE. Huh, J. Ahn, S. Oh, H. Park, J. Youn, JW. Cho (Seongnam, Republic of Korea)
Home-Based Targeted tDCS for Cerebellar Ataxia: Results of a Randomized Double-Blind Crossover Study with Remote Functional Assessment

N. Rozenberg, N. Inbar, M. Abo-Said, P. Ponger, S. Frenkel-Toledo, M. Brozgol, JM. Hausdorff, Z. Yekutieli, S. Springer, T. Gurevich (Tel Aviv, Israel)
Homozygous ATP13A2 Mutation Associated Kufor-Rakeb Syndrome Expanding The Spectrum Of Juvenile Parkinsonism

A. Guechi (Mexico City, Mexico)
Homozygous PRRT2 Frameshift Mutation Presenting with Infantile Onset Seizures and Childhood Episodic Ataxia

P. Bhatele, P. Kukkle (Manipal, India)
HOPFIT: proactive recognition of older in-patients with advanced Parkinson’s disease improves palliative care outcomes and patient autonomy

W. Tai, N. Mcqueen, P. Gonzales (Cambridge, United Kingdom)
Hot and Fast but Still Parkinson’s Disease: A Case of Dyskinesia-Hyperpyrexia Syndrome

T. Coradine, P. Fraiman, D. Salarini, C. Pereira, K. Couto, G. Chung, M. Soares (São Paulo, Brazil)
How Common Is Central Pain in Parkinson’s Disease? A Systematic Review and Meta-Analysis

L. Gomes Pereira, K. Casali Vieira, C. David Antoniazzi, G. Trevisan (Santa Maria, Brazil)
How large must a Parkinson’s disease trial be to detect pharmacogenomic interactions? Power benchmarks derived from the Exenatide PD3 clinical trial

R. Gurney, C. Girges, N. Vijiaratnam, C. Carroll, M. Hu, G. Duncan, M. Silverdale, T. Foltynie (London, United Kingdom)
How Parkinson’s Disease Research Has Shifted from 2016 – 2025 at the MDS Congress: A Topic-Based Analysis

L. Ramin, D. Wolff (Hannover, Germany)
How Remote Coaching Enables Engagement in Physical Activity for People with Parkinson’s Disease in Qatar: A Qualitative Study of Participant and Therapist Perspectives

M. Elamin, Y. Abdulmaguid, R. Abdelsamad, T. Ahmad, M. Shoukry, L. Mohammad, M. Rawash, M. Abunaib, S. Koyili, I. Eltazi, L. Morris, T. Hartley, M. Latrous, M. Almusallam, L. Quinn, H. Khalil (Doha, Qatar)
Hula as an Integrative Movement-Based Therapy: Baseline Cohort Characteristics

R. Shuman, E. Krening, K. Tolentino, M. Yee, K. Thai, M. Faouzi, M. Bruno (Honolulu, USA)
Human Snca Knock-In Mouse as a Model for Synucleinopathy Research

E. Cinar, J. Ma, Y. Liang, K. Luk (Philadelphia, USA)
Huntington’s Disease Genetic Testing Practices in the Lower North Island of New Zealand

D. Llewelyn, D. Bourke (Wellington, New Zealand)
Hybrid deep brain stimulation conversion using the S8 adaptor in Parkinson’s disease

MG. Choi, SJ. Chung, SY. Jo, GY. Lee (Seoul, Republic of Korea)
Hyperkinetic Movement Disorder as the First Manifestation of Gaucher Disease Type 3

B. Kocer, E. Ercan (Ankara, Turkey)

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z